[Lipid - lowering effect of mate tea intake in dyslipidemic subjects].
BACKGROUND
Mate is the national infusion of Argentina and its properties on human health have not been fully elucidated.


OBJECTIVE
To evaluate changes in lipid profile in dyslipidemic patients supplemented with yerba mate.


METHODS
121 dyslipidemic subjects (total cholesterol (TC), LDL cholesterol (LDLC) cholesterol and / or triglycerides (TG) elevated) without lipid-lowering therapy, both sexes (74 women and 47 men) between 40 and 60 years old were studied. After six weeks of mate abstinence, lipid profile and atherogenic index (AI), body composition by anthropometry and recent intake of energy, nutrients and food groups by food frequency questionnaire were analyzed. Daily consumption of mate prepared with 50 g or 100 g of yerba mate was indicated, plus the instruction not to alter eating habits, smoking, medication or exercise. All determinations were repeated after six and twelve weeks. Statistical analysis was performed using Student's T test for paired samples or Wilcoxon test according to normality of the variables (p <0.05).


RESULTS
At the end of twelve weeks, TC fell 9.49% (21.66 mg/dL), LDLC fell 11.95% (17.96 mg/dL) HDLC fell 3.34% (1.65 mg/dL) and AI dropped 6.58% (0.31 points), p <0.001 for all cases. TG decreased 7.02% (10.74 mg/dl; p = 0.029) only in 50 g yerba mate consumers. Anthropometric and nutritional variables did not change significantly.


CONCLUSIONS
Daily consumption of mate produces a time-dependent decrease in TC and its fractions in dyslipidemic subjects.
Laboratorio de Enfermedades Metabólicas y Cáncer. Facultad de Ciencias de la Nutrición. Universidad Juan Agustín Maza. Mendoza, Argentina.. diego_messi@hotmail.com.
Diego
D
Messina
Laboratorio de Enfermedades Metabólicas y Cáncer. Facultad de Ciencias de la Nutrición. Universidad Juan Agustín Maza. Mendoza, Argentina.. csotofarrando@gmail.com.
Catalina
C
Soto
Laboratorio de Enfermedades Metabólicas y Cáncer. Facultad de Ciencias de la Nutrición. Universidad Juan Agustín Maza. Mendoza, Argentina.. ailincme@hotmail.com.
Ailín
A
Méndez
Laboratorio de Enfermedades Metabólicas y Cáncer. Facultad de Ciencias de la Nutrición. Universidad Juan Agustín Maza. Mendoza, Argentina.. carla_corte@hotmail.es.
Carla
C
Corte
Laboratorio de Enfermedades Metabólicas y Cáncer. Facultad de Ciencias de la Nutrición. Universidad Juan Agustín Maza. Mendoza, Argentina.. marian_1819@hotmail.com.
Mariana
M
Kemnitz
Laboratorio de Enfermedades Metabólicas y Cáncer. Facultad de Ciencias de la Nutrición. Universidad Juan Agustín Maza. Mendoza, Argentina.. virgiavena@gmail.com.
Virginia
V
Avena
Laboratorio de Enfermedades Metabólicas y Cáncer. Facultad de Ciencias de la Nutrición. Universidad Juan Agustín Maza. Mendoza, Argentina.. dd.delbalzo@gmail.com.
Diego
D
Del Balzo
Laboratorio de Enfermedades Metabólicas y Cáncer. Facultad de Ciencias de la Nutrición. Universidad Juan Agustín Maza. Mendoza, Argentina.. rafaelpereze@yahoo.com.ar.
Rafael
R
Pérez Elizalde
D000328:Adult; D001823:Body Composition; D002784:Cholesterol / Q000097:blood; D050171:Dyslipidemias / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D030019:Ilex paraguariensis; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; D008055:Lipids; D010936:Plant Extracts; D002784:Cholesterol